Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Great. My name is Gena Wang. I'm SMID-cap biotech analyst at the Barclays. Welcome to our first in-person Global Healthcare Conference post pandemic. I hope pandemic is ending. It's really nice to see everyone in person and I would like to also thank all the participants, investors, companies and especially our event team and the corporate access team who made this event possible.
With that, I would like to introduce our first presenting company, Alnylam. Jeff Poulton, Chief Financial Officer, will be with us today. Thank you very much, Jeff.
Thank you. Nice to be here.
Yes. So before I start with any questions, do you want to just highlight very high-level overview of Alnylam, how much has been achieved in the past several decades now?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
